Tag Archives: Dr. Marijn Dekkers

Bayer Group sales in 2015 reached the highest level in the company’s history

Focus on the Life Sciences following the successful stock market flotation of Covestro / Substantial sales and earnings increases at HealthCare / Good business development at CropScience despite a weaker market environment / Covestro posts strong earnings improvement / Group … Read the full press release

Werner Baumann becomes the new Chairman of the Board of Management of Bayer AG

LEVERKUSEN, 26-Feb-2016 — /EuropaWire/ — Effective May 1, 2016, Werner Baumann will become the new Chairman of the Board of Management of Bayer AG. This was decided by the company’s Supervisory Board at its meeting today. The current CEO of … Read the full press release

Bayer CEO Dr. Dekkers at the “Meet Management” investor conference in Berlin: We are also optimistic for the medium term and have great plans for the Life Science businesses

HealthCare striving for strong sales and margin growth through 2017 / CropScience aims to grow faster than the market and maintain margin at a high level Leverkusen/Berlin, 13-3-2015 — /EuropaWire/ — The Bayer Group aims to achieve strong sales and earnings … Read the full press release

30,000 attended Leverkusen BayArena for Bayer’s 150 years anniversary celebration

Leverkusen, 4-7-2013 — /europawire.eu/ — The Leverkusen BayArena – home stadium of the Bayer 04 soccer team – was transformed into a sea of green and blue. The climax of the afternoon event held to celebrate Bayer’s foundation 150 years ago … Read the full press release

96.4 percent of Conceptus’ shares already owned by Bayer Group

Conceptus imminently to become a wholly-owned Bayer subsidiary Leverkusen, 5-6-2013 — /europawire.eu/ — The Bayer Group has successfully completed its tender offer for the outstanding shares of Conceptus, Inc., Mountain View, California (NASDAQ:CPTS). As of the expiration of the offer period … Read the full press release

Bayer acquired 100% of the shares of Steigerwald Arzneimittelwerk GmbH

Transaction includes Iberogast® and Laif® brands Leverkusen, Germany, 21-5-2013 — /europawire.eu/ —  Bayer signed an agreement Thursday to acquire 100% of the shares of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, a privately held pharmaceutical company specializing in pharmacy-only herbal medicines. Steigerwald’s product … Read the full press release